Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 121, Issue 12, Pages (December 2014)

Similar presentations


Presentation on theme: "Volume 121, Issue 12, Pages (December 2014)"— Presentation transcript:

1 Volume 121, Issue 12, Pages 2348-2355 (December 2014)
Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension  Tin Aung, FRCS, PhD, Guna Laganovska, MD, Tania Josefina Hernandez Paredes, MD, James D. Branch, MD, Alexis Tsorbatzoglou, MD, PhD, Ivan Goldberg, AM, FRANZCO  Ophthalmology  Volume 121, Issue 12, Pages (December 2014) DOI: /j.ophtha Copyright © 2014 American Academy of Ophthalmology Terms and Conditions

2 Figure 1 Patient disposition. BBFC = brinzolamide 1%/brimonidine 0.2% fixed combination; IOP = intraocular pressure; ITT = intent-to-treat. Ophthalmology  , DOI: ( /j.ophtha ) Copyright © 2014 American Academy of Ophthalmology Terms and Conditions

3 Figure 2 The least squares (LS) mean changes in diurnal intraocular pressure (IOP) (i.e., average of IOP at 9 am, 11 am, and 4 pm time points) from baseline throughout the study (intent-to-treat [ITT] population). Error bars represent standard errors. P values for the primary efficacy end point (between-group differences at month 3) and descriptive P values for supportive efficacy end points (i.e., between-group differences at week 2 and month 6) are provided. BBFC = brinzolamide 1%/brimonidine 0.2% fixed combination. *P ≤ †Primary end point. Ophthalmology  , DOI: ( /j.ophtha ) Copyright © 2014 American Academy of Ophthalmology Terms and Conditions

4 Figure 3 Mean change in intraocular pressure (IOP) from baseline at all time points at week 2, month 3, and month 6 visits (intent-to-treat [ITT] population). Error bars represent standard errors. BBFC = brinzolamide 1%/brimonidine 0.2% fixed combination. Ophthalmology  , DOI: ( /j.ophtha ) Copyright © 2014 American Academy of Ophthalmology Terms and Conditions

5 Figure 4 Percentage of patients who achieved intraocular pressure (IOP) <18 mmHg (intent-to-treat [ITT] population). BBFC = brinzolamide 1%/brimonidine 0.2% fixed combination. Ophthalmology  , DOI: ( /j.ophtha ) Copyright © 2014 American Academy of Ophthalmology Terms and Conditions


Download ppt "Volume 121, Issue 12, Pages (December 2014)"

Similar presentations


Ads by Google